Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kolasa

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Gynecologic Oncology|June 24, 2006
PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutationsI K Kolasa, A Rembiszewska, A Janiec-Jankowska, et al.
Cancer Biology & Therapy|November 26, 2008
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patientsIwona K Kolasa, Alina Rembiszewska, Anna Felisiak, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Gynecologic Oncology|June 24, 2006
PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutationsI K Kolasa, A Rembiszewska, A Janiec-Jankowska, et al.
Cancer Biology & Therapy|November 26, 2008
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patientsIwona K Kolasa, Alina Rembiszewska, Anna Felisiak, et al.
Pageof 8